PMID- 21555940 OWN - NLM STAT- MEDLINE DCOM- 20111108 LR - 20151119 IS - 1473-5830 (Electronic) IS - 0954-6928 (Linking) VI - 22 IP - 5 DP - 2011 Aug TI - Biomarker profiles as descriptors of left ventricular remodeling after acute myocardial infarction. PG - 311-6 LID - 10.1097/MCA.0b013e328346b88d [doi] AB - BACKGROUND: Biomarker expression can predict subsequent cardiovascular events. The goal of this study was to determine the pattern of expression in blood of a broad array of cytokines and growth factors taken 24-72 h after an ST elevation myocardial infarction (STEMI) involving the left anterior descending (LAD) coronary artery. METHODS: Blood was taken from 16 patients with LAD STEMI. Cytokine and growth factor expressions were quantified with the use of a Milliplex cytokine/chemokine array analysis that tested 42 analytes. Results from patients were compared with those in blood from 20 healthy volunteers. RESULTS: Most (15/16) participants had positive remodeling without reduction in left ventricular function during follow-up. Analytes were grouped based on their function into those that activate class 1 T-helper cells (Th1 activates cell-mediated immunity), those that activated a Th2 response (activates humoral immunity and attenuates cell-mediated immunity), chemokines (attract leukocytes), and growth factors (promote a healing response). Elevation of cytokines involved in the Th2 response predominated over the Th1 response demonstrating a balance favoring tolerance and limiting activation of cell-mediated immunity. The concentration of selected chemokines favoring cell-mediated immunity was not elevated. The concentration of selected growth factors was increased. CONCLUSION: The cytokine expression, 24-72 h after an LAD STEMI, suggests that positive ventricular remodeling is associated with growth factor expression and limitation of cell-mediated immunity. Subsequent studies are warranted to determine whether deviation from this pattern identifies patients at an increased risk of adverse remodeling after myocardial infarction. FAU - Lam, Phillip H AU - Lam PH AD - Cardiology Division, Department of Medicine, University of Vermont, Burlington, USA. FAU - Anderson, Phillip R 3rd AU - Anderson PR 3rd FAU - Ahmed, Bina AU - Ahmed B FAU - Sobel, Burton E AU - Sobel BE FAU - Vanburen, Peter AU - Vanburen P FAU - Schneider, David J AU - Schneider DJ LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - England TA - Coron Artery Dis JT - Coronary artery disease JID - 9011445 RN - 0 (Biomarkers) RN - 0 (Cytokines) RN - 0 (Intercellular Signaling Peptides and Proteins) SB - IM MH - Adult MH - Aged MH - Aged, 80 and over MH - Biomarkers/*blood MH - Cytokines/*blood MH - Female MH - Humans MH - Immunity, Cellular MH - Intercellular Signaling Peptides and Proteins/*blood MH - Male MH - Middle Aged MH - Myocardial Infarction/*blood MH - Pilot Projects MH - Th1-Th2 Balance MH - Ventricular Remodeling/*physiology EDAT- 2011/05/11 06:00 MHDA- 2011/11/09 06:00 CRDT- 2011/05/11 06:00 PHST- 2011/05/11 06:00 [entrez] PHST- 2011/05/11 06:00 [pubmed] PHST- 2011/11/09 06:00 [medline] AID - 10.1097/MCA.0b013e328346b88d [doi] PST - ppublish SO - Coron Artery Dis. 2011 Aug;22(5):311-6. doi: 10.1097/MCA.0b013e328346b88d.